These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25880516)

  • 1. Myocardial tissue caveolae.
    Sanon VP; Sawaki D; Mjaatvedt CH; Jourdan-Le Saux C
    Compr Physiol; 2015 Apr; 5(2):871-86. PubMed ID: 25880516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caveolae, caveolin, and cavins: potential targets for the treatment of cardiac disease.
    Das M; Das DK
    Ann Med; 2012 Sep; 44(6):530-41. PubMed ID: 21651441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
    Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
    Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Caveolin genes: from cell biology to medicine.
    Williams TM; Lisanti MP
    Ann Med; 2004; 36(8):584-95. PubMed ID: 15768830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinction between signaling mechanisms in lipid rafts vs. caveolae.
    Sowa G; Pypaert M; Sessa WC
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):14072-7. PubMed ID: 11707586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolae and caveolins in the cardiovascular system.
    Gratton JP; Bernatchez P; Sessa WC
    Circ Res; 2004 Jun; 94(11):1408-17. PubMed ID: 15192036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease.
    Hnasko R; Lisanti MP
    Mol Interv; 2003 Dec; 3(8):445-64. PubMed ID: 14993453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ischemia reperfusion injury and epoxyeicosatrienoic acids on caveolin expression in mouse myocardium.
    Chaudhary KR; Cho WJ; Yang F; Samokhvalov V; El-Sikhry HE; Daniel EE; Seubert JM
    J Cardiovasc Pharmacol; 2013 Mar; 61(3):258-63. PubMed ID: 23403888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression.
    Jasmin JF; Mercier I; Hnasko R; Cheung MW; Tanowitz HB; Dupuis J; Lisanti MP
    Cardiovasc Res; 2004 Sep; 63(4):747-55. PubMed ID: 15306231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cav-p60 expression in rat muscle tissues. Distribution of caveolar proteins.
    Voldstedlund M; Vinten J; Tranum-Jensen J
    Cell Tissue Res; 2001 Nov; 306(2):265-76. PubMed ID: 11702238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of caveolin-1 in cardiovascular regulation.
    Rahman A; Swärd K
    Acta Physiol (Oxf); 2009 Feb; 195(2):231-45. PubMed ID: 18826501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cavin proteins: New players in the caveolae field.
    Briand N; Dugail I; Le Lay S
    Biochimie; 2011 Jan; 93(1):71-7. PubMed ID: 20363285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic ablation of caveolin-1 confers protection against atherosclerosis.
    Frank PG; Lee H; Park DS; Tandon NN; Scherer PE; Lisanti MP
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):98-105. PubMed ID: 14563650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae.
    Razani B; Wang XB; Engelman JA; Battista M; Lagaud G; Zhang XL; Kneitz B; Hou H; Christ GJ; Edelmann W; Lisanti MP
    Mol Cell Biol; 2002 Apr; 22(7):2329-44. PubMed ID: 11884617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The caveolar membrane system in endothelium: From cell signaling to vascular pathology.
    Filippini A; Sica G; D'Alessio A
    J Cell Biochem; 2018 Jul; 119(7):5060-5071. PubMed ID: 29637636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype.
    Aravamudan B; Volonte D; Ramani R; Gursoy E; Lisanti MP; London B; Galbiati F
    Hum Mol Genet; 2003 Nov; 12(21):2777-88. PubMed ID: 12966035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolins and cavins in the trafficking, maturation, and degradation of caveolae: implications for cell physiology.
    Busija AR; Patel HH; Insel PA
    Am J Physiol Cell Physiol; 2017 Apr; 312(4):C459-C477. PubMed ID: 28122734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1 null (-/-) mice show dramatic reductions in life span.
    Park DS; Cohen AW; Frank PG; Razani B; Lee H; Williams TM; Chandra M; Shirani J; De Souza AP; Tang B; Jelicks LA; Factor SM; Weiss LM; Tanowitz HB; Lisanti MP
    Biochemistry; 2003 Dec; 42(51):15124-31. PubMed ID: 14690422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
    Smythe GM; Eby JC; Disatnik MH; Rando TA
    J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases.
    Sotgia F; Bonuccelli G; Minetti C; Woodman SE; Capozza F; Kemp RG; Scherer PE; Lisanti MP
    Am J Pathol; 2003 Dec; 163(6):2619-34. PubMed ID: 14633633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.